The Nova Scotia Collaborative Inflammatory Bowel Diseases Clinic uses the fecal calprotectin test to diagnose IBD or distinguish between IBD and IBS. Doctors say this approach allows for better disease management and improves patient outcomes. A second non-invasive test is the point of care intestinal ultrasound, which provides clinicians with real-time images of the intestinal tract, aiding in the diagnosis and monitoring of IBD activity and avoiding traditional endoscopic investigations which are invasive and expensive. The lessons learned by the IBD team are soon being shared nationally.
November 09, 2023